ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2026

Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations.

Nimet Yılmaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.